Executive Profile

Bradford S. Goodwin Co-Founder and Chief Executive Officer, CharlestonPharma, LLC

Age	Total Calculated Compensation	This person is connected to 2 Board Members in 2 different organizations across 7 different industries. See Board Relationships
57	--

Background

Mr. Bradford S. Goodwin, Brad is a Co-Founder of CharlestonPharma, LLC and serves as its Chief Executive Officer. Mr. Goodwin serves as the President and Chief Executive Officer of Keren Pharmaceutical, Inc. Mr. Goodwin serves as Senior Audit Manager of PricewaterhouseCoopers LLP. He was the Founder of Collabra Pharma Inc. and served as its President and Chief Operating Officer from April 2000 to July 2001. He served as the Chief Executive Officer of Novacea Inc. from ... December 2001 to December 7, 2006. Mr. Goodwin has over 25 years of pharmaceutical, business, financial and operational management experience, in the biopharmaceutical industry. He has been active in numerous financings, product licenses and strategic alliances, including playing a significant role in the establishment of the collaboration with IDEC Pharmaceuticals and Genentech's 1995 strategic relationship with Roche. From April 1987 to February 2000, Mr. Goodwin served various senior executive positions at Genentech Inc., including as Vice President of Finance and was responsible for treasury, purchasing, risk management, real estate, controllership, tax and long-range planning and also helped the structure and negotiate significant product licenses, including the license of Rituxan®, and developed long-range strategic plans. Prior to Genentech, Mr. Goodwin served at PricewaterhouseCoopers LLP (formerly Price Waterhouse LLP) as a Certified Public Accountant and Auditor. He served as the Non Executive Chairman of Abbott Biotherapeutics Corp. (Also known as Facet Biotech Corporation). He served as the Chairman of PDL BioPharma Inc., from July 2008 to December 2008. Mr. Goodwin served as Chairman of the Board of CoTherix Inc. from September 2004 to 2007. He has been a Director of NeurogesX, Inc. since August 20, 2009, and Rigel Pharmaceuticals Inc. since January 25, 2007. He serves as a Director of R&D Logic Inc. He served as a Director of Facet Biotech Corporation since November 2008. He served as a Director of PDL Biopharma Inc. from April 20, 2006 to December 2008. He served as a Director of Amedica Corporation since May 6, 2007. He served as a Director of Novacea Inc. from February 2002 to December 7, 2006 and CoTherix Inc. from January 2004 to 2007. Mr. Goodwin holds a B.S. in Business Administration, with specialization in Finance and Accounting from the University of California, Berkeley.

Corporate Headquarters 645 Meeting Street Charleston, South Carolina 29403 United States Phone: 843-789-5907 Fax: -- Board Members Memberships 2002-2006 Former Chief Executive Officer and Member of the Board of Directors Novacea, Inc. 2004-2007 Former Chairman of the Board, Member of the Audit Committee and Member of the Compensation Committee CoTherix, Inc. 2006-2008 Former Chairman of the Board, Chairman of Audit Committee, Member of Finance Committee, Member of Nominating & Governance Committee and Member of Compensation Committee PDL BioPharma, Inc. 2007-Present Director and Chairman of Audit Committee Rigel Pharmaceuticals, Inc. 2007-N/A Former Director, Chairman of Audit Committee and Member of Compensation Committee Amedica Corporation 2008-N/A Former Chairman, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee AbbVie Biotherapeutics Inc. 2009-Present Independent Director, Chairman of Audit Committee and Member of Compensation Committee NeurogesX, Inc. Education BSBA University of California Berkeley Other Affiliations Rigel Pharmaceuticals, Inc. CoTherix, Inc. PDL BioPharma, Inc. NeurogesX, Inc. Novacea, Inc. University of California Berkeley Amedica Corporation AbbVie Biotherapeutics Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.